Product NDC: | 52544-283 |
Proprietary Name: | Crinone |
Non Proprietary Name: | progesterone |
Active Ingredient(s): | 45 mg/1.125g & nbsp; progesterone |
Administration Route(s): | VAGINAL |
Dosage Form(s): | GEL |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52544-283 |
Labeler Name: | Watson Pharma, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020701 |
Marketing Category: | NDA |
Start Marketing Date: | 19970513 |
Package NDC: | 52544-283-24 |
Package Description: | 6 APPLICATOR in 1 CARTON (52544-283-24) > 1.125 g in 1 APPLICATOR |
NDC Code | 52544-283-24 |
Proprietary Name | Crinone |
Package Description | 6 APPLICATOR in 1 CARTON (52544-283-24) > 1.125 g in 1 APPLICATOR |
Product NDC | 52544-283 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | progesterone |
Dosage Form Name | GEL |
Route Name | VAGINAL |
Start Marketing Date | 19970513 |
Marketing Category Name | NDA |
Labeler Name | Watson Pharma, Inc. |
Substance Name | PROGESTERONE |
Strength Number | 45 |
Strength Unit | mg/1.125g |
Pharmaceutical Classes | Progesterone [Chemical/Ingredient],Progesterone [EPC] |